Ibaraki Plant Qualified for "ISO 14001"
Sumitomo Pharmaceuticals hereby announces that its Ibaraki Plant (General Manager: Takeshi Noguchi), the company's medicine manufacturing factory, was approved on July 24 to qualify for "ISO 14001" an international standard for excellent environmental management systems. The examination and registration body is Japan Chemical Quality Assurance Ltd.
The main objectives for acquiring this international standard include:
- (1) To play an active role in the conservation of the global environment, the destruction of which now looms as an international threat, and to fulfill our obligation as a business operating within society;
- (2) To upgrade the system for plant operation by constructing an internationally acceptable management structure.
For our company, the acquisition of ISO 14001 approval is not the final goal in itself. It is a springboard for us to continue our efforts to rectify the present environmental plight and contribute to the conservation of the earth. We also hope that our activities will make our own employees more aware of potential dangers and their responsibility in that regard, in the hope that they will endeavor individually to save energy and resources and reduce daily refuse, and thus contribute in their own way to the cause.
The Ibaraki Plant started in December 1962 as a medicine manufacturing factory of Sumitomo Chemical, Co., Ltd., the forerunner or our present company. It is now one of the most well-equipped, well-functioning factories leading Japan's pharmaceutical industry, with its continuous production line from R&D to manufacturing, packaging, and shipment.
Sumitomo Pharmaceuticals is totally committed to global conservation and will solidly maintain its contribution.